Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-11

Clinical Trial Update: Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 2/3 trial comparing azithromycin plus chloroquine against mefloquine for uncomplicated falciparum malaria in Afric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Chloroquine (chloroquine)
  • Mefloquine (Mefloquine)

Snippet

Sponsor: Pfizer | Conditions: Malaria, Falciparum | Phase 2, Phase 3 | Status: COMPLETED